Polyvalent vaccine-KLH conjugate and OPT-821 with bevacizumab (BEV) in patients with ovarian cancer in second or greater remission Meeting Abstract


Authors: O'Cearbhaill, R. E.; Iasonos, A.; Zhou, Q.; Durany, R.; Aghajanian, C.; Hensley, M. L.; Konner, J. A.; Makker, V.; Tew, W. P.; Fleisher, M.; Sabbatini, P.
Abstract Title: Polyvalent vaccine-KLH conjugate and OPT-821 with bevacizumab (BEV) in patients with ovarian cancer in second or greater remission
Meeting Title: 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 15 Suppl.
Meeting Dates: 2013 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-05-20
Language: English
ACCESSION: WOS:000335419602064
PROVIDER: wos
Notes: Meeting Abstract: 5550 -- Source: Wos
MSK Authors
  1. Vicky Makker
    73 Makker
  2. Jason Konner
    84 Konner
  3. Paul J Sabbatini
    199 Sabbatini
  4. Qin Zhou
    120 Zhou
  5. Alexia Elia Iasonos
    179 Iasonos
  6. Martee L Hensley
    220 Hensley
  7. William P Tew
    122 Tew
  8. Martin Fleisher
    237 Fleisher
  9. Robert Eugene Durany
    3 Durany